Insights into Q-marker of Shensong Yangxin capsule in treating cardiac arrhythmias based on a linear substitution strategy in quantification of multiple components

IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Phytomedicine Pub Date : 2025-01-12 DOI:10.1016/j.phymed.2025.156382
Zi-ting Li , Peng-cheng Zhao , Xiao-xing Wang , Lv-qi Xie , Yan Li , Shui-xing Zhang , Xi-yang Tang , Yi Dai
{"title":"Insights into Q-marker of Shensong Yangxin capsule in treating cardiac arrhythmias based on a linear substitution strategy in quantification of multiple components","authors":"Zi-ting Li ,&nbsp;Peng-cheng Zhao ,&nbsp;Xiao-xing Wang ,&nbsp;Lv-qi Xie ,&nbsp;Yan Li ,&nbsp;Shui-xing Zhang ,&nbsp;Xi-yang Tang ,&nbsp;Yi Dai","doi":"10.1016/j.phymed.2025.156382","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The concept of a Quality marker (Q-marker) has emerged as a crucial tool for ensuring the safety and efficacy of Traditional Chinese Medicine (TCM) formulas. However, significant challenges remained in the identification and practical application of Q-marker, particularly due to the scarcity of reference standards.</div></div><div><h3>Purpose</h3><div>This study aimed to achieve a multidimensional integration of chemical profiling, target tissue distribution and <em>in vivo</em> high-throughput screening model to effectively identify the Q-marker of Shensong Yangxin Capsule (SSYX) and propose a linear substitution strategy for the quantification of multiple components.</div></div><div><h3>Methods</h3><div>First, the chemical constituents of SSYX were detected and systematically characterized using UHPLC/Q-TOF MS. Next, through heart distribution study, high-exposure components <em>in vivo</em> were identified after the oral administration of SSYX. Third, a high-throughput arrhythmia zebrafish model was employed to further screen for key constituents. Finally, potential Q-marker were selected by integrating the aforementioned studies, and a quantification method for the Q-marker was developed using UHPLC-TQ-MS.</div></div><div><h3>Results</h3><div>The results of chemical profiling, heart tissue distribution and anti-arrhythmic activities were integrated into four properties: specificity, traceability from prescription to <em>in vivo</em>, effectiveness and prescription compatibility, which led to the identification of 30 ingredients as potential Q-marker of SSYX. Subsequently, an external standard method (ESM) was developed for these 30 components and applied to the analysis of 10 commercial batches of SSYX. In addition, the feasibility of multi-marker detection <em>via</em> a linear substitution method (LSM) was explored for the first time using SSYX as a case study for method development, based on the stability of linear equations of the compounds in single standard solutions and multi-component mixed standard solutions. The simultaneous quantification of 30 components in SSYX was achieved by employing two linearly stable substances, greatly reducing the amount of standard substances used while maintaining measurability and convenience. A comparison of LSM and ESM revealed no significant difference in the component contents calculated by the two methods, with relative errors within ± 4 %.</div></div><div><h3>Conclusion</h3><div>Our results suggested that 30 ingredients, including six key elements, could be considered as Q-marker of SSYX. Moreover, the LSM strategy offered a novel approach for developing environmentally friendly and convenient methods for the quality control of multi-index components in TCM formulas.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"138 ","pages":"Article 156382"},"PeriodicalIF":8.3000,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytomedicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0944711325000212","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The concept of a Quality marker (Q-marker) has emerged as a crucial tool for ensuring the safety and efficacy of Traditional Chinese Medicine (TCM) formulas. However, significant challenges remained in the identification and practical application of Q-marker, particularly due to the scarcity of reference standards.

Purpose

This study aimed to achieve a multidimensional integration of chemical profiling, target tissue distribution and in vivo high-throughput screening model to effectively identify the Q-marker of Shensong Yangxin Capsule (SSYX) and propose a linear substitution strategy for the quantification of multiple components.

Methods

First, the chemical constituents of SSYX were detected and systematically characterized using UHPLC/Q-TOF MS. Next, through heart distribution study, high-exposure components in vivo were identified after the oral administration of SSYX. Third, a high-throughput arrhythmia zebrafish model was employed to further screen for key constituents. Finally, potential Q-marker were selected by integrating the aforementioned studies, and a quantification method for the Q-marker was developed using UHPLC-TQ-MS.

Results

The results of chemical profiling, heart tissue distribution and anti-arrhythmic activities were integrated into four properties: specificity, traceability from prescription to in vivo, effectiveness and prescription compatibility, which led to the identification of 30 ingredients as potential Q-marker of SSYX. Subsequently, an external standard method (ESM) was developed for these 30 components and applied to the analysis of 10 commercial batches of SSYX. In addition, the feasibility of multi-marker detection via a linear substitution method (LSM) was explored for the first time using SSYX as a case study for method development, based on the stability of linear equations of the compounds in single standard solutions and multi-component mixed standard solutions. The simultaneous quantification of 30 components in SSYX was achieved by employing two linearly stable substances, greatly reducing the amount of standard substances used while maintaining measurability and convenience. A comparison of LSM and ESM revealed no significant difference in the component contents calculated by the two methods, with relative errors within ± 4 %.

Conclusion

Our results suggested that 30 ingredients, including six key elements, could be considered as Q-marker of SSYX. Moreover, the LSM strategy offered a novel approach for developing environmentally friendly and convenient methods for the quality control of multi-index components in TCM formulas.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于多组分定量线性替代策略的参松养心胶囊q标记治疗心律失常的研究
背景:质量标记(Q-marker)的概念已经成为确保中药配方安全性和有效性的重要工具。然而,在q标记物的鉴定和实际应用中仍然存在重大挑战,特别是由于缺乏参考标准。目的:本研究旨在通过化学图谱、靶组织分布和体内高通量筛选模型的多维整合,有效鉴定参松养心胶囊(SSYX)的q标记,并提出多组分定量的线性替代策略。方法:首先采用UHPLC/Q-TOF质谱法检测SSYX的化学成分并对其进行系统表征。其次,通过心脏分布研究,鉴定口服SSYX后体内高暴露成分。第三,采用高通量心律失常斑马鱼模型进一步筛选关键成分。最后,综合上述研究筛选出潜在Q-marker,并建立UHPLC-TQ-MS定量方法。结果:将化学谱分析、心脏组织分布和抗心律失常活性的结果综合到特异性、从处方到体内的可追溯性、有效性和处方相容性四个方面,鉴定出30种成分可能是SSYX的q标记物。随后,为这30种成分开发了外部标准法(ESM),并应用于10批SSYX的分析。此外,基于化合物在单一标准溶液和多组分混合标准溶液中线性方程的稳定性,以SSYX为例,首次探索了通过线性替代法(LSM)进行多标记物检测的可行性。采用两种线性稳定的物质,实现了SSYX中30种组分的同时定量,在保持可测性和便利性的同时,大大减少了标准物质的用量。LSM法和ESM法计算的成分含量差异无统计学意义,相对误差在±4%以内。结论:我们的研究结果表明30种成分,包括6种关键成分,可作为SSYX的Q-marker。此外,LSM策略为开发环境友好、简便的中药配方中多指标成分的质量控制方法提供了新的途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Phytomedicine
Phytomedicine 医学-药学
CiteScore
10.30
自引率
5.10%
发文量
670
审稿时长
91 days
期刊介绍: Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.
期刊最新文献
Lycium barbarum Polysaccharides-enriched extract Ameliorate Rheumatoid Arthritis via Gut microbiota-mediated regulation of the Tfh/B cell axis. Enhancing the efficacy of Salvia miltiorrhiza and Ligusticum chuanxiong in the treatment of coronary heart disease: The value of poorly soluble components and nanocrystal self-stabilized solid emulsions. Naturally derived Erythrinin C targets γ-secretase signaling to suppress triple-negative breast cancer progression and reverse paclitaxel resistance. Shenkangling alleviates renal fibrosis induced by renal ischemia-reperfusion injury by mitigating mitochondrial damage through modulation of the STING signaling pathway. Xia Ku Cao Paste restores intestinal microbiota homeostasis and improves hepatic metabolism disturbances to alleviate hyperlipidemia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1